Role of p16(INK4A) in detection of human papillomavirus DNA and stratification of cancer-specific mortality on the basis of long term follow-up data of 34 patients with invasive penile cancer
Aktuelle Urol 2019; 50(5): 491-501; Bründl J, Neppl C, Hommer T, Otto W, Breyer J, Brookman-May S, Weber F, Burger M, May M, Eichelberg C
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer
BJU Int 2019; 123(1): 187-196; Breyer J, Wirtz RM, Erben P, Rinaldetti S, Worst TS, Stoehr R, Eckstein M, Sikic D, Denzinger S, Burger M, Hartmann A, Otto W
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes
Cancer Immunol Res 2019; Pfannstiel C, Strissel PL, Chiappinelli KB, Sikic D, Wach S, Wirtz R, Wullweber A, Taubert H, Breyer J, Otto W, Worst T, Burger M, Wullich B, Bolenz C, Fuhrich N, Geppert CI, Weyerer V, Stöhr R, Bertz S, Keck B, Erlmeier F, Erben P, Hartmann A, Strick R, Eckstein M
Perioperative antibiotic prophylaxis for stone therapy
Curr Opin Urol 2019; 29(2): 89-95; Schnabel MJ, Wagenlehner FME, Schneidewind L
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab
Eur J Cancer 2019; 106(): 234-243; Eckstein M, Erben P, Kriegmair MC, Worst TS, Weis CA, Wirtz RM, Wach S, Stoehr R, Sikic D, Geppert CI, Weyerer V, Bertz S, Breyer J, Otto W, Keck B, Burger M, Taubert H, Weichert W, Wullich B, Bolenz C, Hartmann A, Erlmeier F
Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016"
Eur Urol Focus 2019; 5(3): 457-466; Compérat EM, Burger M, Gontero P, Mostafid AH, Palou J, Roupret M, van Rhijn BWG, Shariat SF, Sylvester RJ, Zigeuner R, Babjuk M
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer
Eur Urol Focus 2019; 5(2): 224-241; Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Gontero P, Lam T, MacLennan S, Mostafid H, Palou J, van Rhijn BWG, Sylvester RJ, Zigeuner R, Shariat SF, Roupret M
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review
Eur Urol Focus 2019; 5(2): 205-223; Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, MacLennan S, N'Dow J, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Mostafid H, van Rhijn BWG, Gontero P, Palou J, Shariat SF, Roupret M
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma
Hum Pathol 2019; 83(): 212-223; Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A, German Network Of Kidney Cancer
Long-term outcome after grafting with small intestinal submucosa and collagen fleece in patients with Peyronie´s disease: a matched pair analysis
Int J Impot Res 2019; 31(4): 256-262; Rosenhammer B, Sayedahmed K, Fritsche HM, Burger M, Kübler H, Hatzichristodoulou G
The impact of obesity on pulmonary deterioration in patients undergoing robotic-assisted laparoscopic prostatectomy
J Clin Monit Comput 2019; 33(1): 133-143; Blecha S, Harth M, Zeman F, Seyfried T, Lubnow M, Burger M, Denzinger S, Pawlik MT
Improved prediction of nephron-sparing surgery versus radical nephrectomy by the optimized R.E.N.A.L. Score in patients undergoing surgery for renal masses
Minerva Urol Nefrol 2019; 71(3): 249-25; Sterzik A, Solyanik O, Eichelberg C, Jost M, Graser A, Lausenmeyer EM, Otto W, Waidelich R, Stief CG, Burger M, May M, Brookman-May SD
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts
Transl Oncol 2019; 12(4): 661-66; Sikic D, Wirtz RM, Wach S, Dyrskjøt L, Erben P, Bolenz C, Breyer J, Otto W, Hoadley KA, Lerner SP, Eckstein M, Hartmann A, Keck B
Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava
Urol Int 2019; (): 1-8; Spachmann PJ, Breyer J, Kalogirou C, Lausenmeyer EM, Weber F, Prohaska S, Denzinger S, Burger M, Kübler H, Otto W, Vergho D
Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer
Urol Int 2019; 102(1): 77-8; Lausenmeyer EM, Braun K, Breyer J, Gierth M, Denzinger S, Burger M, Voelker HU, Otto W
Erratum to 'Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534]
Urol Oncol 2019; 37(3): 227-227; Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P
Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series
Urol Oncol 2019; 37(5): 300.e9-300.e15; Haider M, Ladurner C, Mayr R, Tandogdu Z, Fritsche HM, Fradet V, Comploj E, Pycha A, Lemire F, Lacombe L, Fradet Y, Toren P, Lodde M
Urology must be fit for the future: Comprehensive medical care of the urogenital tract by two separate but integrated systems
Urologe A 2019; 58(2): 178-180; Burger M
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder
Virchows Arch 2019; 474(2): 209-217; Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, Keck B, Hartmann A, Bolenz C, BRIDGE Consortium e.V.
Hospital volume in ureterorenoscopic stone treatment: 99 operations per year could increase the chance of a better outcome-results of the German prospective multicentre BUSTER project
World J Urol 2019; 37(4): 743-749; Lebentrau S, Enzmann T, Lehsnau M, Christoph F, Schostak M, May M, BUSTER study group
Wake-up call for more doctor-patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer
World J Urol 2019; 37(1): 215-217; Gilfrich C, Maurer O, Spachmann PJ, Dombrowski MK, Burger M, May M
Impact of previous urethroplasty on the outcome after artificial urinary sphincter implantation: a prospective evaluation
World J Urol 2019; Sayedahmed K, Olianas R, Kaftan B, Omar M, El Shazly M, Burger M, Mayr R, Rosenhammer B
Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis
World J Urol 2019; Rosenhammer B, Ganzer R, Zeman F, Näger T, Fritsche HM, Blana A, Burger M, Bründl J
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz(at)csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie(at)csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
